4.6 Article

Antioxidant activity against H2O2-induced cytotoxicity of the ethanol extract and compounds from Pyrola decorate leaves

Journal

PHARMACEUTICAL BIOLOGY
Volume 55, Issue 1, Pages 1843-1848

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/13880209.2017.1333126

Keywords

Pyrolaceae; terpenoids; oxidative stress; isolation

Funding

  1. Youth Innovative Training Fund for College Students of Wuhan University of Science and Technology [201610488041]
  2. Pearl River S& T Nova Program of Guangzhou [201610010017]
  3. Guangdong Special Support Project for Outstanding Young Scholars

Ask authors/readers for more resources

Context: The leaves of Pyrola decorate H. Andr (Pyrolaceae), known as Luxiancao, have long been used for treating kidney deficiency, gastric haemorrhage and rheumatic arthritic diseases in traditional Chinese medicine. Objective: The phytochemicals and antioxidant capacities in vitro of P. decorate leaves were investigated. Materials and methods: Ethanol, petroleum ether, acetidin, n-butyl alcohol and aqueous extracts of Pyrola decorate leaves were prepared by solvent sequential process, and then isolated and purified to obtain phytochemicals. Cell viability was measured by MTT assay. PC12 cells were pretreated for 24h with different extractions of P. decorate leaves at concentrations of 0.1, 0.5, 1, 5 and 10mg/mL, then H2O2 of 0.4mM was added in all samples for an additional 2h. The antioxidant capacities of betulin, ursolic acid and monotropein were determined in PC12 cells against H2O2 induced cytotoxicity in vitro as well. Results: Nine compounds (1-9) were isolated and structurally determined by spectroscopic methods, especially 2D NMR analyses. Ethanol extract treated groups showed inhibitory activity with IC50 value of 10.83mg/mL. Betulin, ursolic acid and monotropein were isolated from P. decorate, and demonstrated with IC50 values of 6.88, 6.15 and 6.13g/mL, respectively. Discussion and conclusions: In conclusion, Pyrola decorate is a potential antioxidative natural plant and worth testing for further pharmacological investigation in the treatment of oxidative stress related neurological disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available